Related Experiment Video

Updated: May 6, 2026

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
12:27

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

Published on: April 2, 2014

16.2K

[Advance in the research on P2X7 and inflammatory respiratory diseases]

Shu-Hua Cao1, Shao-Peng Yuan, Qi Hou

  • 1Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing 100050, China.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|November 6, 2013
PubMed

Insights

The P2X7 receptor plays a key role in inflammation. This review explores its potential as a therapeutic target for respiratory diseases like asthma, COPD, and lung cancer.

Area of Science:

  • Immunology
  • Pharmacology
  • Respiratory Medicine

Background:

  • The P2X7 receptor (P2X7) is a critical ATP receptor involved in inflammatory signaling.
  • P2X7 is linked to inflammatory mediators such as IL-1beta and IL-18, suggesting its role in inflammatory conditions.
  • P2X7 antagonists have shown promise in reducing inflammatory responses in vitro and in vivo.

Purpose of the Study:

  • To review the current understanding of P2X7 receptor structure, distribution, and biological activities.
  • To investigate the role of P2X7 in inflammatory respiratory diseases, including asthma, COPD, and lung cancer.
  • To discuss the therapeutic potential of P2X7 antagonists for these conditions.

Main Methods:

  • Literature review of existing research on P2X7.
  • Analysis of studies focusing on P2X7's involvement in inflammatory pathways.
  • Examination of P2X7 antagonist development and preclinical/clinical data.

Main Results:

  • P2X7 is implicated in the pathogenesis of various inflammatory diseases.
  • Evidence suggests P2X7's involvement in asthma, COPD, and lung cancer, though research is limited.
  • P2X7 antagonists represent a promising therapeutic strategy for inflammatory respiratory diseases.

Conclusions:

  • P2X7 is a significant therapeutic target for inflammatory respiratory diseases.
  • Further research is warranted to fully elucidate P2X7's role in asthma, COPD, and lung cancer.
  • Development of P2X7 antagonists holds potential for novel treatments.

More Related Videos

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

46.4K
A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide08:33

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

Published on: December 15, 2014

11.1K

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
77
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
360
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K